Company Background

Founded in 2014, PRP Concepts™ Inc., acquired the CASCADE® Autologous Platelet System from MTF Biologics (MTF) in 2021. CASCADE was originally developed as a point-of-care treatment for chronic non-healing wounds, and orthopedic and spinal fusion procedures that require a viable concentration of intact platelets. Platelets in the CASCADE System continuously release growth factors over several days. The product is an FDA cleared medical device.

In Pursuit of Exceptional Outcomes

PRP Concepts is steadfastly committed to the further development of safe and effective products that may leverage the clinical attributes of the Cascade system for wound care, orthopedics, sports medicine, aesthetics, podiatry, and other surgical applications. Please see our discussion of the company’s three ongoing prospective, randomized, controlled clinical trials in the treatment of diabetic foot ulcers, venous leg ulcers, and pressure ulcers; it can be seen on the ongoing clinical studies page of this site.


To establish the CASCADE Autologous Platelet System as the gold standard in advanced wound care and orthopedics

Limitations in the standard of wound care and unmet clinical needs, as well as the desire for better outcomes and improved quality of life by patients and healthcare providers, will continue to drive medical innovation.

PRP Concepts has created a unique PRP centrifuge device and therapy system for regenerative medicine that will:

  • Improve outcomes using advanced products that provide clinical benefit for patient health care
  • Reduce treatment costs
  • Increase ease of use for health care providers
  • Invest in expanded product R&D and marketing to become a leader in regenerative medicine

To improve patient outcomes through continued research and development building on core CASCADE technology

We seek to reinvent how rapid point-of-care cell therapy technology is applied to a variety of regenerative tissue applications that are critical to improving patients’ quality of life. Our solutions embrace a widely available off-the-shelf tool set that is easy to use on-site, has a low overall cost, leverages the patients’ own blood as the source of fresh cells, and takes place within 40 minutes.

The team at PRP Concepts is committed to developing therapeutics that are easy to prepare and administer, provide clinical benefits, and can be used in a wide array of settings, and we are indeed achieving our milestones.